Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 290.40
-6.90 (-2.32%)
Jul 21, 2026, 11:20 AM CET
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 20.88 billion as of July 20, 2026. Its market cap has decreased by -18.98% in one year.
Market Cap
20.88B
Enterprise Value
6.83B
Revenue
9.24B
Ranking
n/a
PE Ratio
3.32
Stock Price
290.40
ChartMarket Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 20.88B, an increase of 1,385.50%. That is a compound annual growth rate of 18.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 20.88B | -36.44% |
| Dec 30, 2025 | 32.85B | -35.01% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.46T |
| Genmab | 114.74B |
| Coloplast | 95.20B |
| Demant | 58.59B |
| ALK-Abelló | 53.18B |
| H. Lundbeck | 41.26B |
| Ambu A/S | 18.23B |
| Bavarian Nordic | 14.06B |